TNFSF11 and plasma cell myeloma: The observation that myeloma cells in the spleen were not affected by the RANKL treatment confirmed that the effect on dormant cells was a non-cell-autonomous effect mediated by osteoclasts in the bone (Lawson et al., 2015).